SCHEMBL22501697

SCHEMBL22501697

C#CCN(CC1CC1)c1ccc2c(C)cc(=O)oc2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 6/20 0.78
▸ ALDH1A1 P00352 10/20 0.58
▸ GLA P06280 6/20 0.58
▸ HPGD P15428 6/20 0.58
▸ HSD17B10 Q99714 6/20 0.58
▸ CASP1 P29466 3/20 0.58
▸ CASP7 P55210 3/20 0.58
▸ L3MBTL1 Q9Y468 3/20 0.58
▸ CYP3A4 P08684 2/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ ATM Q13315 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ CA12 O43570 3/20 0.49
▸ CA9 Q16790 3/20 0.49
▸ CA4 P22748 1/20 0.49
▸ KDM4E B2RXH2 7/20 0.48
▸ GAA P10253 5/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MAOB P27338 4/20 0.46
▸ MAOA P21397 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22501617 0.89 ALDH1A1 (0.68) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501632 0.88 IGLV6-57 (1.00) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501624 0.84 IGLV6-57 (1.00) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501592 0.82 IGLV6-57 (0.83) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501590 0.81 IGLV6-57 (0.69) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL24590085 0.81 IGLV6-57 (0.80) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501608 0.81 IGLV6-57 (0.80) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL22501824 0.80 IGLV6-57 (0.78) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL24590066 0.80 IGLV6-57 (0.78) IGLV6-57ALDH1A1GLAHPGDHSD17B10
SCHEMBL24589955 0.79 IGLV6-57 (0.78) IGLV6-57ALDH1A1GLAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed
EP-3946604-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS The Scripps Research Institute (US) 2022-02-09 — — EP disclosed
WO-2020205683-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE (US) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885ALDH1A1 2072/4885GLA 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback